4Kelly DF, Moxon ER, Pollard AT. Haem Ophilus influenzae type b conjugate vaeclnes[J].Immundogy,2004,113(2): 163-174.
5Kyung H, Kin MD, Dong Sookim MD. Rcaction of scla of the Korean children free from hib invasive diseases against hinflueazae type bcapsular polysaeeharide antigen[J].J Korean Med Sci,1994,9(1):1-8.
7Kelly DF, Moxon ER, Pollard AJ. Haemophilus influenzae type b conjugate vaccines [J]. Immunology, 2004, 113(2): 163-174.
8Nascimento-Carvalho CM, De Andrade AL. Haemophilus influen- zae type b vaccination: long-term protection [J]. J Pediatr(Rio J), 2006, 82(3 Suppl): S109-S114.
9Merritt J, Allard G, O'Toole L, et ol. Development and scale-up of a fed-batch process for the production of capsular polysaccharide from Haemophilus influenza [J]. J Biotechnol, 2000, 81 (2-3): 189-197.
10Takagi M, Cabrera-Crespo J, Bamque-Ramos J, et al. Characteri- zation of polysaccharide production of Haemophilus influertzoe type b and its relationship to bacterial cell growth [J]. Appl Biochem Biotechnol, 2003, 110 (2) :91-100.
